H1N1 Vaccine Deaths in Germany: German doctors issued warning about swine flu jab


The German Professional Assocation of Environmental Doctors, (Deutschen Berufsverbands der Umweltmediziner) issued a press release on November 9th warning of the “significant health risks” of using GlaxoSmithKline’s Pandemrix for mass vaccinations in view of the lack of data on its safety, especially for pregnant women and children.

The press release predicted the kind of deaths that are now being reported in Germany as a result of people taking the Pandemrix jab. The BILD newspaper today admitted that at least seven people have died after taking the shot in Germany so far.

The DBU notes out that GSK and pharma companies have been given immunity for any deaths or damage that their vaccines cause by the government leaving patients to bear all the risks.

In addtion, the DBU states that the adjuvant squalene — illegal in the US and UK — causes a proinflammatory response, activates the immune system and is immunogenic when taken as a subcutaneous or intramuscular injection and can provoke autoimmune diseases such as those found among US and UK soldiers who took squalene as part of the anthrax vaccine.

Studies on squalene, carried out mainly by pharma companies and WHO, did not assess side effects and so do not give the full picture.

The German government and the Paul Ehrlich Institute have systematically ignored the huge body of scientific evidence indicating the swine flu jab is dangerous and so exposed people to an unacceptable risk.


Articles by: Global Research

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]